Myasthenia gravis (Guidelines)

Audience

NHS Highland
Primary and Secondary Care
Adults only

This guidance has been approved to be used on an interim basis while awaiting more comprehensive guidance being developed.

Drugs to avoid in myasthenia gravis

Some medications should be avoided or are contraindicated in myasthenia gravis.

It is appreciated that clinicians need a quick reference resource for drugs to avoid in Myasthenia Gravis, to date there are multiple sources available and further work needs to be done to compile this information into a useable format. In the meantime NHS Highland recommends the following resource to be used in the first instance.

GGC clinical guideline: Myasthenia Gravis or Lambert-Eaton Myasthenia Syndrome, Medicines that may affect patients

Management of myasthenia gravis

BMJ Best practice: Myasthenia gravis - Management Approach | BMJ Best Practice
UptoDate: Overview of the treatment of myasthenia gravis - UpToDate (Sign in to UptoDate may be required)

Further information for Health Care Professionals

Other sources that include information on this are listed below. Please note that these sources may differ in content and from the information provided above. If you have any concerns please discuss with neurology.

Myaware: Drugs to avoid
Myasthenia gravis foundation of America: Cautionary Drugs (myasthenia.org)

Last reviewed: 27/06/2024

Next review date: 30/06/2025

Author(s): Department of Neurology.

Version: 1

Approved By: TAMSG of the ADTC

Reviewer name(s): D Horne (Medical Lead Pharmacist), Dr J Carod Artal (Neurology Consultant).

Document Id: TAM645

References

Patient information

Myaware is a charity that provides support, advice and research for people affected by mysasthenia
MySelf-Management | Highland, Scotland